Table of Contents Executive Summary 1 Industry Overview of Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug 1.1 Definition of Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug 1.2 Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Segment by Type 1.2.1 Global Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Production Growth Rate Comparison by Types (2014-2025) 1.2.2 VAL-301 1.2.3 GLPG-1492 1.2.4 Solithromycin 1.2.5 Acorafloxacin Hydrochloride 1.2.6 Others 1.3 Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Segment by Applications 1.3.1 Global Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Consumption Comparison by Applications (2014-2025) 1.3.2 Hospital 1.3.3 Clinic 1.3.4 Others 1.4 Global Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Overall Market 1.4.1 Global Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Revenue (2014-2025) 1.4.2 Global Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Production (2014-2025) 1.4.3 North America Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Status and Prospect (2014-2025) 1.4.4 Europe Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Status and Prospect (2014-2025) 1.4.5 China Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Status and Prospect (2014-2025) 1.4.6 Japan Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Status and Prospect (2014-2025) 1.4.7 Southeast Asia Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Status and Prospect (2014-2025) 1.4.8 India Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Status and Prospect (2014-2025) 2 Manufacturing Cost Structure Analysis 2.1 Raw Material and Suppliers 2.2 Manufacturing Cost Structure Analysis of Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug 2.3 Manufacturing Process Analysis of Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug 2.4 Industry Chain Structure of Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug 3 Development and Manufacturing Plants Analysis of Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug 3.1 Capacity and Commercial Production Date 3.2 Global Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Manufacturing Plants Distribution 3.3 Major Manufacturers Technology Source and Market Position of Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug 3.4 Recent Development and Expansion Plans 4 Key Figures of Major Manufacturers 4.1 Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Production and Capacity Analysis 4.2 Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Revenue Analysis 4.3 Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Price Analysis 4.4 Market Concentration Degree 5 Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Regional Market Analysis 5.1 Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Production by Regions 5.1.1 Global Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Production by Regions 5.1.2 Global Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Revenue by Regions 5.2 Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Consumption by Regions 5.3 North America Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Market Analysis 5.3.1 North America Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Production 5.3.2 North America Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Revenue 5.3.3 Key Manufacturers in North America 5.3.4 North America Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Import and Export 5.4 Europe Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Market Analysis 5.4.1 Europe Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Production 5.4.2 Europe Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Revenue 5.4.3 Key Manufacturers in Europe 5.4.4 Europe Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Import and Export 5.5 China Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Market Analysis 5.5.1 China Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Production 5.5.2 China Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Revenue 5.5.3 Key Manufacturers in China 5.5.4 China Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Import and Export 5.6 Japan Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Market Analysis 5.6.1 Japan Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Production 5.6.2 Japan Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Revenue 5.6.3 Key Manufacturers in Japan 5.6.4 Japan Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Import and Export 5.7 Southeast Asia Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Market Analysis 5.7.1 Southeast Asia Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Production 5.7.2 Southeast Asia Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Revenue 5.7.3 Key Manufacturers in Southeast Asia 5.7.4 Southeast Asia Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Import and Export 5.8 India Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Market Analysis 5.8.1 India Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Production 5.8.2 India Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Revenue 5.8.3 Key Manufacturers in India 5.8.4 India Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Import and Export 6 Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Segment Market Analysis (by Type) 6.1 Global Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Production by Type 6.2 Global Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Revenue by Type 6.3 Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Price by Type 7 Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Segment Market Analysis (by Application) 7.1 Global Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Consumption by Application 7.2 Global Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Consumption Market Share by Application (2014-2019) 8 Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Major Manufacturers Analysis 8.1 Allergan Plc 8.1.1 Allergan Plc Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Production Sites and Area Served 8.1.2 Allergan Plc Product Introduction, Application and Specification 8.1.3 Allergan Plc Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.1.4 Main Business and Markets Served 8.2 Galapagos NV 8.2.1 Galapagos NV Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Production Sites and Area Served 8.2.2 Galapagos NV Product Introduction, Application and Specification 8.2.3 Galapagos NV Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.2.4 Main Business and Markets Served 8.3 Merck & Co Inc 8.3.1 Merck & Co Inc Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Production Sites and Area Served 8.3.2 Merck & Co Inc Product Introduction, Application and Specification 8.3.3 Merck & Co Inc Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.3.4 Main Business and Markets Served 8.4 Syntiron LLC 8.4.1 Syntiron LLC Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Production Sites and Area Served 8.4.2 Syntiron LLC Product Introduction, Application and Specification 8.4.3 Syntiron LLC Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.4.4 Main Business and Markets Served 8.5 Valevia UK Ltd 8.5.1 Valevia UK Ltd Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Production Sites and Area Served 8.5.2 Valevia UK Ltd Product Introduction, Application and Specification 8.5.3 Valevia UK Ltd Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.5.4 Main Business and Markets Served 9 Development Trend of Analysis of Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Market 9.1 Global Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Market Trend Analysis 9.1.1 Global Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Market Size (Volume and Value) Forecast 2019-2025 9.2 Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Regional Market Trend 9.2.1 North America Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Forecast 2019-2025 9.2.2 Europe Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Forecast 2019-2025 9.2.3 China Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Forecast 2019-2025 9.2.4 Japan Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Forecast 2019-2025 9.2.5 Southeast Asia Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Forecast 2019-2025 9.2.6 India Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Forecast 2019-2025 9.3 Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Market Trend (Product Type) 9.4 Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Market Trend (Application) 10.1 Marketing Channel 10.1.1 Direct Marketing 10.1.2 Indirect Marketing 10.3 Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Customers 11 Market Dynamics 11.1 Market Trends 11.2 Opportunities 11.3 Market Drivers 11.4 Challenges 11.5 Influence Factors 12 Conclusion 13 Appendix 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Author List 13.4 Disclaimer

List of Tables and Figures Figure Picture of Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Table Global Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Production (K Pcs) Growth Rate Comparison by Types (2014-2025) Figure Global Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Production Market Share by Types in 2018 Figure VAL-301 Product Picture Figure GLPG-1492 Product Picture Figure Solithromycin Product Picture Figure Acorafloxacin Hydrochloride Product Picture Figure Others Product Picture Table Global Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Consumption (K Pcs) Comparison by Applications (2014-2025) Figure Global Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Consumption Market Share by Applications in 2018 Figure Hospital Figure Clinic Figure Others Figure Global Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Revenue (Million USD) (2014-2025) Figure Global Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Production (K Pcs) (2014-2025) Figure North America Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Market Size (Million USD) (2014-2025) Figure Europe Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Market Size (Million USD) (2014-2025) Figure China Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Market Size (Million USD) (2014-2025) Figure Japan Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Market Size (Million USD) (2014-2025) Figure Southeast Asia Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Market Size (Million USD) (2014-2025) Figure India Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Market Size (Million USD) (2014-2025) Table Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Raw Material and Suppliers Table Manufacturing Cost Structure Analysis of Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug in 2018 Figure Manufacturing Process Analysis of Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Figure Industry Chain Structure of Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Table Capacity and Commercial Production Date of Key Manufacturers Table Global Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Manufacturing Plants Distribution Table Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Major Manufacturers Technology Source and Market Position Table Recent Development and Expansion Plans in Future Table Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Capacity (K Pcs) of Major Manufacturers (2014-2019) Table Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Production (K Pcs) of Major Manufacturers (2014-2019) Table Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Production Market Share of Major Manufacturers (2014-2019) Figure Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Production Share by Manufacturers in 2018 Table Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Revenue (Million US$) of Major Manufacturers (2014-2019) Table Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Revenue Market Share of Major Manufacturers (2014-2019) Figure Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Revenue Share by Manufacturers in 2018 Table Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Average Price (USD/Pcs) of Major Manufacturers (2014-2019) Table Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table Global Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Production by Regions 2014-2019 (K Pcs) Table Global Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Production Market Share by Regions 2014-2019 Figure Global Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Production Market Share by Regions in 2018 Table Global Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Revenue by Regions 2014-2019 (Million USD) Table Global Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Revenue Market Share by Regions 2014-2019 Figure Global Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Revenue Market Share by Regions in 2018 Table Global Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Consumption by Regions 2014-2019 (K Pcs) Table Global Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Consumption Market Share by Regions 2014-2019 Figure North America Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Production Growth Rate 2014-2019 (K Pcs) Figure North America Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Revenue Growth Rate 2014-2019 (Million USD) Table North America Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Production, Consumption Import and Export (K Pcs) Figure Europe Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Production Growth Rate 2014-2019 (K Pcs) Figure Europe Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Revenue Growth Rate 2014-2019 (Million USD) Table Europe Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Production, Consumption Import and Export (K Pcs) Figure China Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Production Growth Rate 2014-2019 (K Pcs) Figure China Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Revenue Growth Rate 2014-2019 (Million USD) Table China Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Production, Consumption Import and Export (K Pcs) Figure Japan Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Production Growth Rate 2014-2019 (K Pcs) Figure Japan Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Revenue Growth Rate 2014-2019 (Million USD) Table Japan Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Production, Consumption Import and Export (K Pcs) Figure Southeast Asia Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Production Growth Rate 2014-2019 (K Pcs) Figure Southeast Asia Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Revenue Growth Rate 2014-2019 (Million USD) Table Southeast Asia Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Production, Consumption Import and Export (K Pcs) Figure India Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Production Growth Rate 2014-2019 (K Pcs) Figure India Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Revenue Growth Rate 2014-2019 (Million USD) Table India Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Production, Consumption Import and Export (K Pcs) Figure Global Consumption Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Market Share by Application (2014-2019) Figure Global Value (Consumption) Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Market Share by Application (2014-2019) Table Allergan Plc Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Production Sites and Area Served Table Allergan Plc Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Product Introduction, Application and Specification Table Allergan Plc Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019) Table Allergan Plc Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Production Growth Rate (2014-2019) Table Allergan Plc Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Production Market Share (2014-2019) Figure Allergan Plc Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Revenue Market Share (2014-2019) Table Allergan Plc Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Main Business and Markets Served Table Galapagos NV Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Production Sites and Area Served Table Galapagos NV Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Product Introduction, Application and Specification Table Galapagos NV Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019) Table Galapagos NV Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Production Growth Rate (2014-2019) Table Galapagos NV Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Production Market Share (2014-2019) Figure Galapagos NV Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Revenue Market Share (2014-2019) Table Galapagos NV Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Main Business and Markets Served Table Merck & Co Inc Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Production Sites and Area Served Table Merck & Co Inc Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Product Introduction, Application and Specification Table Merck & Co Inc Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019) Table Merck & Co Inc Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Production Growth Rate (2014-2019) Table Merck & Co Inc Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Production Market Share (2014-2019) Figure Merck & Co Inc Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Revenue Market Share (2014-2019) Table Merck & Co Inc Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Main Business and Markets Served Table Syntiron LLC Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Production Sites and Area Served Table Syntiron LLC Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Product Introduction, Application and Specification Table Syntiron LLC Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019) Table Syntiron LLC Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Production Growth Rate (2014-2019) Table Syntiron LLC Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Production Market Share (2014-2019) Figure Syntiron LLC Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Revenue Market Share (2014-2019) Table Syntiron LLC Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Main Business and Markets Served Table Valevia UK Ltd Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Production Sites and Area Served Table Valevia UK Ltd Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Product Introduction, Application and Specification Table Valevia UK Ltd Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019) Table Valevia UK Ltd Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Production Growth Rate (2014-2019) Table Valevia UK Ltd Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Production Market Share (2014-2019) Figure Valevia UK Ltd Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Revenue Market Share (2014-2019) Table Valevia UK Ltd Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Main Business and Markets Served Figure Global Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Production (K Pcs) Growth Rate Forecast 2019-2025 Figure Global Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Revenue (Million USD) Growth Rate Forecast 2019-2025 Figure Global Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales Price (USD/Pcs) Forecast 2019-2025 Figure North America Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Production Growth Rate Forecast 2019-2025 (K Pcs) Figure North America Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Europe Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Production Growth Rate Forecast 2019-2025 (K Pcs) Figure Europe Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure China Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Production Growth Rate Forecast 2019-2025 (K Pcs) Figure China Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Japan Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Production Growth Rate Forecast 2019-2025 (K Pcs) Figure Japan Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Southeast Asia Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Production Growth Rate Forecast 2019-2025 (K Pcs) Figure Southeast Asia Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure India Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Production Growth Rate Forecast 2019-2025 (K Pcs) Figure India Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Revenue Growth Rate Forecast 2019-2025 (Million USD) Table Global Production (K Pcs) of Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug by Type (2019-2025) Table Global Consumption (K Pcs) of Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug by Application (2019-2025) Table Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Distributors List Table Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Customers List Table Market Key Trends Table Key Opportunities Table Market Key Drivers Table Key Challenges Table Key Influence Factors Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Allergan Plc Galapagos NV Merck & Co Inc Syntiron LLC Valevia UK Ltd